## Core Concept
Isotope scanning, also known as nuclear medicine or radionuclide imaging, involves the use of small amounts of radioactive tracers to diagnose and determine the severity or treatment of a variety of diseases, including many types of cancers, heart disease, gastrointestinal, endocrine, and neurological disorders. The tracers are typically attached to a pharmaceutical or compound that targets a specific organ or tissue. The imaging modalities commonly used include Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT).

## Why the Correct Answer is Right
The correct answer, , implies that the statement regarding isotope scanning being false is related to its characteristics or applications. Without the specific details of each option, we can infer that the correct answer relates to a fundamental aspect of isotope scanning that is not accurate.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because, without specifying what A states, we can infer that it aligns with accurate characteristics or applications of isotope scanning.
- **Option B:** Similarly, this option is incorrect as it presumably presents a true statement about isotope scanning.
- **Option C:** This is also incorrect for the same reason; it likely represents a factual aspect of isotope scanning.

## Clinical Pearl / High-Yield Fact
A key point to remember is that isotope scanning, particularly with PET and SPECT, offers functional information about tissues and organs, complementing the anatomical details provided by CT or MRI scans. For example, in oncology, PET scans with FDG (fluorodeoxyglucose) can highlight areas of high metabolic activity suggestive of cancer.

## Correct Answer: D.